E ndoglin (CD105) is an auxiliary receptor for the transforming growth factor-β receptor complex. Upregulated endoglin expression has been reported during wound healing and tumor vascularization and in inflammatory tissues and developing embryos. [1] [2][3] Mutations in ENG cause type 1 hereditary hemorrhagic telangiectasia (HHT1), a disease characterized by arteriovenous malformation (AVM) in multiple organs and telangiectasia (small AVM) in the skin, mucous membranes. 4 Furthermore, a common genetic polymorphism in ENG (207G>A) has been associated with increased risk of sporadic brain AVM. 5 Although this polymorphism is synonymous (does not alter encoded amino acid), the A allele reduces the predicted binding score of SRp40, a splicing protein, 6 which could influence endoglin protein production.
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Patients with HHT1 have a higher prevalence of lung AVMs than other patients with HHT. 7 One of the major consequences of lung AVM is the increased risk of paradoxical embolism in the systemic circulation through arteriovenous shunting, which can cause embolic ischemic brain injury. The effect of ENG mutation on recovery from stroke and brain surgery is not clear. In this study using a mouse ischemic stroke model, we tested the hypothesis that ENG deficiency weakens brain injury repair through impaired angiogenesis and macrophage function. We further analyzed the association between a functional polymorphism in endoglin and outcomes after brain AVM rupture and surgical resection of unrupture AVM in patients with sporadic AVM.
Materials and Methods
The Materials and Methods are described in detail in the online-only Data Supplement.
Background and Purpose-Endoglin deficiency causes hereditary hemorrhagic telangiectasia-1 and impairs myocardial repair. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia-1 are associated with a high incidence of paradoxical embolism in the cerebral circulation and ischemic brain injury. We hypothesized that endoglin deficiency impairs stroke recovery.
Methods-Eng heterozygous (Eng

+/-
) and wild-type mice underwent permanent distal middle cerebral artery occlusion (pMCAO). Pial collateral vessels were quantified before pMCAO. Infarct/atrophic volume, vascular density, and macrophages were quantified in various days after pMCAO, and behavioral function was assessed using corner and adhesive removal tests on days 3, 15, 30, and 60 after pMCAO. The association between ENG 207G>A polymorphism and brain arteriovenous malformation rupture and surgery outcome was analyzed using logistic regression analysis in 256 ruptured and 157 unruptured patients. 8 and their wild-type (WT) littermates were used. Tail genomic DNA was used to identify mouse genotype through polymerase chain reaction using primers: R(R9b): 5ʹ-tgagcctgacgggaaactg-3ʹ, and F(F9a): 5ʹ-accatcttgtcctgagtagcg-3ʹ. Eng expression in the brain of Eng +/-mouse is reduced to ≈59% of the level in WT mouse.
Results-After
9
Human Study
Eligible patients with AVM with modified Rankin Scale outcome data and DNA for genetic studies were identified from the University of California, San Francisco, Brain AVM Study Project, an ongoing prospective longitudinal cohort study. Patients (n=245) who presented with an intracerebral hemorrhage and had outcome data available after hemorrhage but before treatment were referred to as the natural history cohort. Patients (n=353) who underwent microsurgical excision of a brain AVM between 2000 and 2011 with outcome data available before and after treatment were referred to as the surgical cohort. All patients signed informed consent to participate, and the study was approved by the Committee for Human Research at University of California, San Francisco.
Statistical Analysis
One-way ANOVA was performed followed by Bonferroni post hoc to analyze the difference of the means of infarct/atrophic volume, vessel density, and the number of CD68 + cells at the peri-infarct region among groups.
For analyses of the behavior test, Gaussian distribution was tested using d'Agostino and Pearson omnibus normality test. Equalities of variances were tested using the F test. For dual comparisons, t tests (Student, Mann-Whitney for non-Gaussian distribution, and Welch correction for unequal variances) were used when appropriate. To test the effect of genotype (WT versus Eng +/-) in the acute phase (day 3 after permanent distal middle cerebral artery occlusion [pMCAO]), we performed a Student t test. To test the effect of genotype in the postacute phase (days 7-60 after pMCAO), we used a mixed-effects linear regression model (taking into account the genotype and the number of days since the insult, after checking 2-way interactions involving the genotype) to predict the specified behavior outcome.
Sample sizes were 10 per group for the behavior test, 13 Eng +/-and 12 WT mice for infarct volume measurement on day 1, 7 per group for infarct/atrophic volume on days 3 and 60, 3-week-old and (6 WT and 6 Eng +/-) and 11-week-old (8 WT and 4 Eng +/-) mice for collateral quantification, and 6 per group for vessel density and CD68 + cell quantification. Data are presented as mean±SD. A 2-tailed P value <0.05 was considered statistically significant.
For human data, univariable and multivariable logistic regression analyses of outcomes were performed. Results are reported as odds ratios (ORs) and 95% confidence intervals (95% CIs). Before constructing multivariate models, we tested whether the effect of ENG 207G>A genotype on outcomes was modified by other predictors (ie, interactions) using likelihood-ratio testing. A significant interaction (P=0.05) was observed in the surgical cohort between ENG 207G>A genotype and hemorrhagic presentation, thus all surgical results are presented stratified as ruptured versus unruptured. Predictors in the multivariable models included ENG 207G>A genotype, age at presentation, sex, race/ethnicity (whites versus nonwhites), AVM size, exclusively deep venous drainage, and eloquent location.
Results
Endoglin Deficiency Delayed Functional Recovery
Adhesive removal and corner tests were used. After the training phase, the baseline behavior results were similar in all Figure 1A and 1B).
In 
Endoglin Deficiency Impairs CD68 + Macrophage Recruitment or Clearance
CD68
+ macrophages were quantified in the peri-infarct region right outside the infarct border on days 3 and 60 after pMCAO. Eng +/-mice had fewer microphages on day 3 (34±6% of total cells versus 40±4%; P=0.009) and more macrophages on day 60 (17±4% versus 13±3%; P=0.02) when compared with WT mice (Figure 3 ), indicating that endoglin deficiency delayed macrophage homing and clearance or promoted macrophage homing at the postacute stage of ischemic stroke.
Endoglin Deficiency Reduced Angiogenic Response to Ischemic Brain Injury
Among the factors determining infarct volume after stroke, collateral vessel anatomy (especially the collateral vessel number between the anterior cerebral artery and the MCA) has been proposed as a major factor determining infarct volume. 10 We quantified the collateral vessel numbers before pMCAO and found no difference between the Eng +/-and WT mice at 3 (21±1.8 versus 21±0.8 vessels/mm 2 ; P=0.56) and 11 (20±2.1 versus 21±2.9; P=0.6; Figure 4A and 4B) weeks. However, microvascular density in the peri-infarct area was lower in Eng +/-mice than in WT mice (417±69 versus 490±52 vessels/mm 2 ; P=0.05; Figure 4C and 4D) on day 60 after pMCAO, indicating that endoglin deficiency reduced postischemic angiogenesis.
ENG 207G>A Allele Is Associated With Poor Outcome After Brain AVM Surgical Resection in Unruptured Patients
Characteristics of patients with good and bad outcomes, stratified by hemorrhage, are presented in Table I Poor outcome patients were also more likely to carry the A allele (P=0.05) and had shorter latencies between hemorrhage and treatment (P<0.01). There were no notable differences in patient age, race/ethnicity, Spetzler-Martin distribution, AVM size, drainage pattern, or location (Table II in the online-only Data Supplement) for those included in the natural history cohort.
Logistic regression results (Table 2) show that the A allele of ENG 207G>A was associated with having a modified Rankin Scale >2 after AVM rupture after adjustment for baseline modified Rankin Scale and time between hemorrhage and modified Rankin Scale assessment (OR, 2.88; 95% CI, 1.10-7.75; P=0.03). Multivariable analysis showed this effect to be independent of other risk factors (OR, 3.21; 95% CI, 1.19-8.68; P=0.02).
Discussion
In this study, we demonstrated that endoglin deficiency impairs brain ischemic injury repair. Eng +/-mice had more severe functional defects and larger atrophic volume than WT mice, which 
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is associated with delayed macrophage homing and clearance or enhanced macrophage homing at the subacute stage.
Although Eng +/-and WT mice had a similar number of collaterals between anterior cerebral artery and MCA at baseline, Eng +/-mice had lower vessel density at the peri-infarct region than WT mice 60 days after pMCAO, which suggests that endoglin deficiency leads to reduced response to angiogenic stimulation. Furthermore, we found that in humans, there was an association between functional polymorphism in endoglin and outcome of brain AVM rupture and surgery.
Endoglin is highly expressed in proliferating vascular endothelial cells 11 and is elevated in the settings of inflammation and wound healing. 12 After ischemia-reperfusion injury and myocardial infarction, endoglin is upregulated in the ischemic area and border zone. 13 , macrophages after VEGF (50 ng/mL) treatment. 15 In the brain, VEGF-induced upregulation of VEGF receptor 2 expression is greatly impaired in Eng +/-mice. 16 Together, these data suggest that reduced angiogenesis in response to injury is one of the mechanisms for impaired tissue repair in Eng +/-mice after pMCAO. Interestingly, Eng +/-mice had more severe brain injury than WT mice even on day 1 after pMCAO, which could not be explained by impairment of tissue repair. Hypoxia induces endothelial endoglin expression, 17 and endoglin prevents apoptosis in hypoxia endothelial cells. 18 Hence, vascular damage in Eng +/-mice could be more severe than in WT mice after ischemic insult. Endoglin haploinsufficiency has been associated with reduced nitric oxide production and increased endothelial nitric oxide synthase-derived superoxide production. 19 Bioavailability of nitric oxide is lower in Eng +/-mice than in WT mice. 20 Nitric oxide produced by endothelial cell induces vascular relaxation. 21 Thus, reduced vessel relaxation and increased vascular damage, together with oxidative stress (more superoxide production), in Eng +/-mice enhance brain injury during the acute stage of ischemic stroke.
In addition to endothelial cells, several other cell types also express endoglin. For example, endoglin is present in monocytes and is upregulated during the monocyte to macrophage transition. 22 Recruitment of human monocytes to the infarcted murine heart and subsequent vessel formation was severely impaired when HHT1 monocytes were used. 13 Endoglin deficiency in endothelial cell reduced leukocyte adhesion and transmigration 23 and impaired the endothelial-autonomous capacity to upregulate stromal cell-derived factor 1 (SDF-1) expression in response to hindlimb ischemic injury. 24 In this study, we found that Eng +/-mice had fewer CD68 + cells in the peri-infarct area at 3 days and more CD68 + cells at 60 days after pMCAO. Taken together, endoglin deficiency seems to impair monocyte adhesion and migration. Additional studies are needed to determine whether increased macrophage in Eng +/-mice at the postacute stage is the result of delayed clearance or prolonged/enhanced macrophage homing at this stage.
The roles of postischemic inflammation are bidirectional. 25 The postischemic inflammatory response contributes to secondary brain injury, and inflammation can be detrimental, because the influx of inflammatory cells amplifies brain cell death. However, during recovery inflammation may be construed as plastic forms of tissue remodeling. 26 How the impaired macrophage homing and clearance impair brain injury recovery need to be explored in future studies.
ENG is a causative gene of HHT1. The prevalence of brain AVM in patients with HHT1 is 1000-fold higher than the prevalence in the general population (10/100 000). 27 A common genetic polymorphism in ENG (207G>A) has also been associated with increased risk of sporadic brain AVM. 5 Furthermore, patients with HHT1 have a high prevalence of lung AVMs, 7 which increases the risk of embolic ischemic brain injury. An insertion/deletion polymorphism in ENG has also been associated with sporadic primary intracranial hemorrhage. 28 Our study is the first to demonstrate that ENG polymorphisms are associated with recovery after brain AVM rupture or surgery in patients. Thus, endoglin may play a crucial role in all types of injury repair, including ischemic stroke, hemorrhagic stroke, or iatrogenic injury. Using an ischemic stroke mouse model, we showed that reduced angiogenesis, impaired macrophage homing, and delayed inflammation resolution could be the underlying mechanism. Additional studies are needed to determine whether the same mechanism applies to all brain injuries.
Conclusions
In this study, we have demonstrated that endoglin deficiency exacerbates ischemic brain injury and delays neurobehavioral recovery in mice, which is associated with reduced angiogenesis, impaired CD68 + cells homing, and delayed inflammation resolution. Endoglin may also play a role in surgical and hemorrhagic recovery in patients with human brain AVM. Understanding how endoglin is involved in different kinds of brain injury could provide new therapeutic opportunities to improve outcomes in patients.
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Materials and Methods
Animal Study Experimental Stroke Model (pMCAO)
Mice were anesthetized via isoflurane inhalation or ketamine (100 mg/kg) and xylene (5 mg/kg). Under a surgical microscope, a 1-cm incision was made between the right orbit and tragus. A piece of 2 mm 2 skull was removed. The arachnoid was opened, and the middle cerebral artery (MCA) was permanently occluded with electrocoagulation (Fine Science Tools, Foster City, CA, USA). The temporal muscle was repositioned, and the skin closed. Body temperature was maintained at 37±0.5°C using a thermal blanket throughout the surgical procedure, and system blood pressure was monitored using tail-cuff system from Visitech Systems (Apex, NC, USA). Surface cerebral blood flow (sCBF) was monitored during MCAO procedure as described below. Mice were excluded from the experiment if sCBF in the ischemic core region measured more than 15% of the baseline.
Brain samples were collected 1, 3 and 14 days after pMCAO (n=10~12 per group).
Infarct/atrophic volumes were evaluated 1, 3 and 60 days after pMCAO; CD 68 + cell-infiltration was quantified on samples collected 3 and 60 days after pMCAO.
Behavioral Tests
Corner Test. Mice were placed between two boards with identical dimensions (30 X 20 X 1 cm 2 ) to detect sensorimotor and postural asymmetries. were not recorded.
Adhesive Removal Test.
To assess the forepaw lateral sensitivity and point out a possible somatosensory neglect, we performed the adhesive removal test.
was applied on each paw and the time that it took to remove the tape from each paw was recorded with a maximum testing time of 120 seconds. Mice were trained two times daily for 4 days before the pMCAO procedure in order to obtain an optimal level of performance. The time to remove the adhesive was recorded in 2 rounds of trials before pMCAO (D0) and 3, 15, 30 and 60 days after.
Evaluation of Infarct and Atrophic Size
Infarct volume at 1 day after pMCAO was measured as previously described. 3 Briefly, brain sections were removed after euthanasia. Each section was inspected under a stereomicroscope and imaged to identify the location of cauterization and MCA branching pattern, and to validate the success of permanent occlusion. Subsequently, the section was sliced into nine 1-mm coronal sections using a brain matrix. Slices were stained with 2% tetraxolium chloride (TTC) as previously described. 3 Infarct volume was the sum of infarct areas in all slides. 3 The edematous change of the brain slices, if present, was corrected accordingly. Obvious atrophy in the ischemic hemisphere can be seen at 7 days after MCAO. 5 Therefore, we and other investigators have used atrophic volume to evaluate brain injury at the subacute stage of ischemic stroke. 5, 6 We assessed atrophic volume in the groups collected 60 days after pMCAO. The infarct area was calculated as the normal area of the ischemic hemisphere subtracted from the non-ischemic hemisphere. The atrophy volume was reconstructed using serial sections.
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Vessel Quantification
Pial Collateral Vessel Number. The collateral vessel number measurement was performed using a dye-enhanced technique with modification. 8 Since the collateral circulation reaches the adult density by 3 weeks of age and remains constant for many months, we measured collateral phenotypes at age p21. Briefly, animals were first anesthetized with ketamine (100 mg/kg) and xylene (5 mg/kg). The animal was perfused through left cardiac ventricle with freshly made buffer composed of adenosine (1mg/ml), paparverine (40 ug/ml) and heparin (25mg/ml) in phosphate-buffered saline to wash out blood. The dorsal calvarium was removed to expose the brain before dye infusion. Polyurethane (PU4ii, VasQtec, Switzerland) with adequate viscosity to avoid capillary filling (1:1 resin:2-Butanone) was slowly infused through left cardiac ventricle. The cerebral circulation was monitored under stereomicroscope during infusion. The brain surface was topically rinsed with 10% formalin then left for 20 minutes to allow the dye to solidify before overnight storage in 10% formalin. The number of collateral vessels connecting the anterior cerebral artery (ACA) and middle cerebral artery (MCA) on both hemispheres were counted and measured under a stereomicroscope, as previously described with modifications. 
Quantification of Macrophages
Two coronal sections adjacent to the sections used for vessel-quantification were incubated with an antibody specific to CD68 + (1:50, AbD Serotec, Raleigh, NC, USA) at 4°C 
Human Study Genotyping
The ENG 207G>A polymorphism (rs16930129) was genotyped by template-directed dye-terminator incorporation assay or microarray (Affymetrix Genome-wide Human SNP Array 6.0) as part of other ongoing studies in the group. Subjects (n=155) were genotyped using both methods, with 99.99% concordance. In cases of disagreement, the PCR-based result was used.
Genotype data was available for 263 patients in the surgical cohort and 170 in the natural history cohort.
Outcomes and Primary Predictors
For the surgical cohort, the primary outcome was change in modified Rankin Scale (mRS) score, calculated as the difference between the final postoperative mRS and preoperative mRS scores. A difference less than or equal to zero (improved or unchanged) was defined as good outcome. Worsening of mRS or death, difference greater than zero, was defined as poor outcome. 10, 11 For the natural history cohort, poor outcome was defined as mRS >2 because of the short timeline after a hemorrhage event and before treatment for post-hemorrhage mRS assessment.
ENG 207G>A genotype was the primary predictor. Carriers of the minor A allele (G/A and A/A genotypes) were compared to non-carriers (G/G genotype).
